Aibar-Almazán A, Voltes-Martínez A, Castellote-Caballero Y, Afanador-Restrepo DF, Carcelén-Fraile MDC, López-Ruiz E (2022) Current status of the diagnosis and management of osteoporosis. Int J Mol Sci 23:9465. https://doi.org/10.3390/ijms23169465

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anish RJ, Nair A (2024) Osteoporosis management-current and future perspectives - a systemic review. J Orthop 53:101–113. https://doi.org/10.1016/j.jor.2024.03.002

Article  PubMed  Google Scholar 

Appelman-Dijkstra NM, Oei HLDW, Vlug AG, Winter EM (2022) The effect of osteoporosis treatment on bone mass. Best Pract Res Clin Endocrinol Metab 36:101623. https://doi.org/10.1016/j.beem.2022.101623

Article  PubMed  Google Scholar 

Baccaro LF, Conde DM, Costa-Paiva L, Pinto-Neto AM (2015) The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil. Clin Interv Aging 10:583–591. https://doi.org/10.2147/CIA.S54614

Article  PubMed  PubMed Central  Google Scholar 

Bach SM, Fortuna MA, Attarian R, Trimarco JT, Catalán CAN, Av-Gay Y, Bach H (2011) Antibacterial and cytotoxic activities of the sesquiterpene lactones cnicin and onopordopicrin. Nat Prod Commun 6:163–166. https://doi.org/10.1177/1934578X11006002

Article  CAS  PubMed  Google Scholar 

Baron R, Hesse E (2012) Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives. J Clin Endocrinol Metab 97:311–325. https://doi.org/10.1210/jc.2011-2332

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhatnagar A, Kekatpure AL (2022) Postmenopausal osteoporosis: a literature review. Cureus 14:e29367. https://doi.org/10.7759/cureus.29367

Article  PubMed  PubMed Central  Google Scholar 

Bijelic R, Milicevic S, Balaban J (2017) Risk factors for osteoporosis in postmenopausal women. Med Arch 71:25. https://doi.org/10.5455/medarh.2017.71.25-28

Article  PubMed  PubMed Central  Google Scholar 

Blumer MJ, Hausott B, Schwarzer C, Hayman AR, Stempel J, Fritsch H (2012) Role of tartrate-resistant acid phosphatase (TRAP) in long bone development. Mech Dev 129:162–176. https://doi.org/10.1016/j.mod.2012.04.003

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brewer L, Williams D, Moore A (2011) Current and future treatment options in osteoporosis. Eur J Clin Pharmacol 67:321–331. https://doi.org/10.1007/s00228-011-0999-2

Article  CAS  PubMed  Google Scholar 

Charde SH, Joshi A, Raut J (2023) A comprehensive review on postmenopausal osteoporosis in women. Cureus 15:e48582. https://doi.org/10.7759/cureus.48582

Article  PubMed  PubMed Central  Google Scholar 

Chen B, Li GF, Shen Y, Huang XI, Xu YJ (2015) Reducing iron accumulation: a potential approach for the prevention and treatment of postmenopausal osteoporosis. Exp Ther Med 10:7–11. https://doi.org/10.3892/etm.2015.2484

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen YJ, Jia LH, Han TH, Zhao ZH, Yang J, Xiao JP, Yang HJ, Yang K (2024) Osteoporosis treatment: current drugs and future developments. Front Pharmacol 15:1456796. https://doi.org/10.3389/fphar.2024.1456796

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clynes MA, Harvey NC, Curtis EM, Fuggle NR, Dennison EM, Cooper C (2020) The epidemiology of osteoporosis. Br Med Bull 133:105–117. https://doi.org/10.1093/bmb/ldaa005

Article  PubMed  Google Scholar 

Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359–2381. https://doi.org/10.1007/s00198-014-2794-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, Hofbauer LC, Lau E, Lewiecki EM, Miyauchi A, Zerbini CA (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375:1532–1543. https://doi.org/10.1056/NEJMoa1607948

Article  CAS  PubMed  Google Scholar 

Cosman F, Miller PD, Williams GC, Hattersley G, Hu MY, Valter I, Fitzpatrick LA, Riis BJ, Christiansen C, Bilezikian JP, Black D (2017) Eighteen months of treatment with subcutaneous abaloparatide followed by 6 months of treatment with alendronate in postmenopausal women with osteoporosis: results of the ACTIVExtend trial. Mayo Clin Proc 92:200–210. https://doi.org/10.1016/j.mayocp.2016.10.009

Article  CAS  PubMed  Google Scholar 

da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, Jüni P, Trelle S (2017) Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet 390:e21–e33. https://doi.org/10.1016/S0140-6736(17)31744-0

Article  PubMed  Google Scholar 

De Leon-Oliva D, Barrena-Blázquez S, Jiménez-Álvarez L, Fraile-Martinez O, García-Montero C, López-González L, Torres-Carranza D, García-Puente LM, Carranza ST, Álvarez-Mon MÁ, Álvarez-Mon M, Diaz R, Ortega MA (2023) The RANK-RANKL-OPG System: a multifaceted regulator of homeostasis, immunity, and cancer. Medicina 59:1752. https://doi.org/10.3390/medicina59101752

Article  PubMed  PubMed Central  Google Scholar 

de Villiers TJ (2024) Bone health and menopause: osteoporosis prevention and treatment. Best Pract Res Clin Endocrinol Metab 38:101782. https://doi.org/10.3390/medicina5910175210.1016/j.beem.2023.101782

Article  PubMed  Google Scholar 

Demiroz T, Albayrak G, Nalbantsoy A, Gocmen B, Baykan S (2018) Anti-inflammatory properties of Centaurea calolepis Boiss. and cnicin against Macrovipera lebetina obtusa (Dwigubsky, 1832) and Montivipera xanthina (Gray, 1849) venoms in rat. Toxicon 152:37–42. https://doi.org/10.1016/j.toxicon.2018.07.016

Article  CAS  PubMed  Google Scholar 

Ek-Rylander B, Flores M, Wendel M, Heinegård D, Andersson G (1994) Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro. J Biol Chem 269:14853–14856. https://doi.org/10.1016/S0021-9258(17)36541-9

Article  CAS  PubMed  Google Scholar 

Erel SB, Karaalp C, Bedir E, Kaehlig H, Glasl S, Khan S, Krenn L (2011) Secondary metabolites of Centaurea calolepis and evaluation of cnicin for anti-inflammatory, antioxidant, and cytotoxic activities. Pharm Biol 49:840–849. https://doi.org/10.3109/13880209.2010.551538

Article  CAS  PubMed  Google Scholar 

Fitzpatrick LA (2002) Secondary causes of osteoporosis. Mayo Clin Proc 77:453–468. https://doi.org/10.4065/77.5.453

Gerdhem P, Ivaska KK, Alatalo SL, Halleen JM, Hellman J, Isaksson A, Pettersson K, Väänänen HK, Åkesson K, Obrant KJ (2004) Biochemical markers of bone metabolism and prediction of fracture in elderly women. J Bone Miner Res 19:386–393. https://doi.org/10.1359/JBMR.0301244

Article  CAS  PubMed  Google Scholar 

Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson BK, Kanis JA (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136. https://doi.org/10.1007/s11657-013-0136-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hofbauer LC, Heufelder AE (2001) Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology. J Mol Med 79:243–253. https://doi.org/10.1007/s001090100226

Article  CAS  PubMed  Google Scholar 

Hu R, Liu W, Li H, Yang L, Chen C, Xia ZY, Guo LJ, Xie H, Zhou HD, Wu XP, Luo XH (2011) A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation. J Biol Chem 286:12328–12339. https://doi.org/10.1074/jbc.M110.176099

Article